Compumedics (ASX:CMP) Total Equity: A$23.37 Mil (As of Dec. 2025)


ASX:CMP Compumedics Ltd ASX:CMP
61 GF Score
Price A$0.26
GF Value A$0.31
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Compumedics Total Equity?

Compumedics ASX:CMP +2.00% 61 Total Equity is A$23.37 Mil as of Dec. 2025. GuruFocus rates ASX:CMP with a GF Score™ of 61/100 and a GF Value™ of A$0.31 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Compumedics's total equity for the quarter that ended in Dec. 2025 was A$23.37 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Compumedics Total Equity Historical Data

* Premium members only.

The historical data trend for Compumedics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compumedics Total Equity Chart

Compumedics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.16 23.59 18.72 18.02 21.71

Compumedics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.03 18.02 21.39 21.71 23.37
ASX:CMP
61GF Score
Compumedics Ltd ASX:CMP
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compumedics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Compumedics's Total Equity for the fiscal year that ended in Jun. 2025 is calculated as

Total Equity=Total Assets(Q: Jun. 2025 )-Total Liabilities(Q: Jun. 2025 )
=54.341-32.633
=21.71

Compumedics's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=54.182-30.808
=23.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of A$23.37 Mil mean?
Compumedics (ASX:CMP) has a Total Equity of A$23.37 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Compumedics and its competitors.
Is Compumedics' Total Equity too high?
Compumedics' current Total Equity is A$23.37 Mil. Overall, Compumedics has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Compumedics' Total Equity compare to ABT and SYK?
Compumedics' Total Equity of A$23.37 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Compumedics and its competitors. Compumedics's current Total Equity is A$23.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compumedics stock overvalued right now?
Based on GuruFocus' analysis, Compumedics (ASX:CMP) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.31, compared to a current price of A$0.26 — trading 17.7% below its estimated fair value. The current Total Equity is A$23.37 Mil. Compumedics' overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Compumedics (ASX:CMP), the current Total Equity is A$23.37 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Compumedics (ASX:CMP) Overvalued in 2026?

Based on GuruFocus' analysis, Compumedics stock appears to be undervalued. The current stock price of A$0.26 is trading 17.7% below its estimated GF Value™ of A$0.31. GuruFocus considers Compumedics to be Modestly Undervalued.

Key valuation signals for ASX:CMP:

  • Total Equity: A$23.37 Mil
  • GF Value™: A$0.31 vs. price of A$0.26 (17.7% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the ASX:CMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Compumedics Business Description

Address 30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
61GF Score

Get the complete analysis for ASX:CMP

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.26
Price
A$0.31
GF Value